Know What's Happening in Healthcare
Know What's Happening in Healthcare
FDA approves first CIRM‑funded gene‑editing therapy for rare immune disorder
The FDA has granted approval to KRESLADI, a gene‑editing therapy from Rocket Pharmaceuticals that treats severe leukocyte adhesion deficiency‑I in children without a matching bone‑marrow donor. It is the first product directly funded by California’s Institute for Regenerative Medicine (CIRM), highlighting the agency’s impact on translational research.
Also developing:
By the numbers: Syneron Bio raises $150M Series B
A mother’s plea after the FDA halted the Elevidys gene‑therapy trial for her son with Duchenne muscular dystrophy has reignited criticism of the 2018 Right‑to‑Try Act. The agency’s decision, triggered by two deaths in a broader trial, cuts off a potential lifeline for patients and underscores the clash between safety oversight and rapid access.
Reimagine Care announced a major upgrade to its AI‑powered virtual oncology assistant, Remi, shifting from rule‑based scripts to natural‑language understanding that can interpret complex patient messages. The SMS‑based platform now adds safety guardrails, AI‑assisted clinician summaries, and expanded monitoring for...
The 2025 British Social Attitudes survey shows only one‑in‑five people under 35 are satisfied with the NHS, compared with more than a third of those over 65. Overall satisfaction rose to 26%, the first increase since before the Covid pandemic,...
This robot was designed for elderly care. It can have conversations with the user, measure blood pressure and heart rate, operate the smart elements of the house from heat to lights and do simpler tasks. It's quite the accomplishment (or claims) for...
As a medical school professor, this is one of the most terrifying feedback loops I've seen in medicine. UC Davis researchers just published in Science showing how chronic kidney disease hijacks gut bacteria to destroy your kidneys FASTER. The mechanism: 1. Damaged kidneys...
GrayMatters Health announced the appointment of five expert advisors to accelerate the commercial growth of Prism, its digital brain‑biomarker platform for PTSD and depression. The advisors—former Congressman Patrick J. Kennedy and psychiatrists Owen Scott Muir, Linda Carpenter, Kenneth Pages, and...
Researchers from EMBL Heidelberg and partner institutions have created the first detailed map of immune and stromal cell organization within human lymph nodes, revealing how this architecture deteriorates in lymphomas. They discovered an inflammatory vicious cycle where T‑cell interferon signals...
Noble’s SureStartRx™ program ships remote demonstration kits to patients before their first self‑injectable dose, allowing them to practice and build confidence. The initiative accelerates therapy initiation, improves short‑term adherence, and extends treatment persistence. Director Sean Glynn highlights how this early...
Six years after the Center for Countering Digital Hate (CCDH) released its “Disinformation Dozen” list, the targeted anti‑vaccine figures recount extensive deplatforming, revenue loss, and personal harassment. The Biden administration’s pressure on major platforms amplified the censorship, while the list’s...
The Vitamin D Lie Your Doctor May Still Believe The official recommendation was based on a mathematical mistake. The "normal" level on your lab report may be dangerously low. And the best fix isn't a pill — it's free https://x.com/robertlufkinmd/status/2036754584954167391
Japan’s Ministry of Health, Labour and Welfare approved Dupixent (dupilumab) for adults with moderate-to-severe bullous pemphigoid, marking the first targeted therapy for the disease in the country. The approval is based on the phase II/III ADEPT trial, which enrolled 106...
A failed IVF cycle is most often traced to embryonic chromosomal abnormalities, not the transfer itself, with implantation rates dropping from about 43% for women under 35 to roughly 9% for those over 41. The article outlines seven primary failure...
Maze Therapeutics reported that its Phase 2 trial of the genetic kidney disease candidate MZ‑001 achieved its primary efficacy and safety goals, showing a roughly 30% slowdown in eGFR decline versus placebo. The double‑blind study enrolled 150 patients with autosomal dominant...
A 74‑year‑old Texas woman with a documented Do‑Not‑Resuscitate (DNR) order was rushed to the ER, where staff performed CPR and intubated her despite verbal confirmation of her wishes. Hospital policy required a physical DNR form filed by registration, which the...
A University of Toronto study published in JAMA Network Open found that preschoolers who consume high levels of ultra‑processed foods at age three are more likely to exhibit anxiety, aggression, hyperactivity and fearfulness by age five. The analysis of over...
The East Kent Hospitals NHS Trust delayed reporting a suspected meningitis case at Queen Elizabeth the Queen Mother Hospital by two days, breaching the Health Protection Regulations that require immediate notification. The lag slowed contact tracing and public warnings, contributing...
WuXi Biologics reported record 2025 results, with revenue up 16.7% and IFRS gross profit climbing 30.9%, lifting its gross margin to 46%. The growth was driven by expanding research, development and manufacturing contracts and tighter cost control across its global...
Health care has become better at saving people once they are already in trouble. That does not mean we have become good at catching trouble early. This episode of The Podcast by KevinMD gets at a hard truth in cardiac care: we...
Based on previous form $MRK will probably now rerun the $TERN study, just to prove to itself that the data were real.
Adolescents represent a hidden segment of the tuberculosis epidemic, with roughly 750,000 teens contracting TB worldwide each year and about 20,000 cases in South Africa alone. Because health data split patients into children or adults, teenagers fall between categories, leading...
$MAZE - Analysts pitching tent poles over the AMKD data, yet stock is down pre market. What's the disconnect?
It's amazing that 25 years after Gleevec we are still watching drug companies pay billions for new drugs for CML. And that, in Adam's previous story, a once deadly cancer was referred to as a chronic disease. Anyway, $MRK buys $TERN...
Researchers at the Salk Institute identified the protein Med14 as the molecular bridge that links GLP‑1 agonist drugs to broad genomic responses that enhance pancreatic beta‑cell health. The team showed that phosphorylation of Med14 is essential for activating gene programs...
$AVXL pulled its blarcamesine Alzheimer's application from the EMA after regulators there said there was no fking way it was going to approve a drug that does not work.
The €2.2 billion (≈$2.42 billion) national children’s hospital in Ireland has missed its 18th deadline, with contractor Bam confirming it will not achieve substantial completion by 30 April 2026. The National Paediatric Hospital Development Board (NPHDB) has invoked contract rights, including withholding 15% of...
Sarah London has become the youngest-ever female CEO of a Fortune 500 company, taking the helm of Centene, the nation’s largest Medicaid insurer. She is steering the firm through steep federal Medicaid cuts and rising health‑care costs by trimming non‑core...
Novo Nordisk and United Laboratories reported Phase‑II data for the GLP‑1 agonist UBT251 in 211 Chinese patients with type‑2 diabetes. Over 24 weeks, UBT251 achieved a 2.16 % HbA1c reduction, outperforming semaglutide’s 1.77 % and placebo’s 0.66 % from a baseline of 8.12 %....
A commentary in Nature Reviews Cardiology, authored by researchers from Maharishi International University, UCLA and Wayne State, argues that Transcendental Meditation can lower stress‑related cardiovascular risk. The paper cites decades of trials showing blood‑pressure reductions and slower atherosclerosis progression, and...
Gilead announced a $2.1 billion acquisition of Ouro Medicines and its T‑cell engager OM336, planning to split the deal with long‑time partner Galapagos. Johnson & Johnson and Protagonist Therapeutics secured FDA approval for Icotyde, an IL‑23 receptor blocker that becomes Protagonist’s...
Basecamp Research has launched the Trillion Gene Atlas, a platform that will collect and model genetic information from more than 100 million species, expanding known evolutionary diversity by roughly 100‑fold. The initiative aims to give AI models a vastly broader biological...
Why Rubber Dams Matter in Precision Dental Procedures by @IntEngineering #MedTech #HealthTech #Tech #Healthcare #TechForGood https://t.co/cRySPYX43q
Merck & Co. is in advanced talks to acquire Terns Pharmaceuticals in an all‑cash transaction valued at about $6 billion. The deal would add a promising rare‑cancer therapy to Merck’s portfolio and could be announced as early as Wednesday.
New York State announced the rollback of its Essential Plan, ending near‑free health insurance for about 460,000 low‑income residents. The move eliminates a key safety‑net, prompting concerns from advocates and insurers about coverage gaps and market disruption.
A multinational research team has created magnetic silk‑iron nanocomposite particles that can be steered with external magnetic fields to deliver therapeutics directly to otherwise inaccessible tissues. The breakthrough promises higher efficacy and lower side‑effects for treatments ranging from cancer to...
Pfizer and French biotech Valneva announced that their experimental Lyme disease vaccine, PF-07307405, achieved 73.2% efficacy in a Phase III trial, marking the most advanced effort to bring a U.S. Lyme vaccine to market despite missing its primary statistical benchmark. The...
A genomic survey of over 18,000 *Escherichia coli* genomes has mapped 90 capsular K‑loci, revealing that five capsule types (K1, K5, K52, K2, K14) cause more than half of bloodstream and urinary‑tract infections in Europe. The study links these high‑risk...
Researchers at Australia’s Peter Doherty Institute have created a portable, CRISPR‑based diagnostic that simultaneously detects syphilis, HSV, chlamydia and gonorrhea in under an hour. The assay also identifies a key antibiotic‑resistance gene in gonorrhea, delivering 97‑100% accuracy compared with laboratory...
Merck (MSD) has entered a multi‑year research partnership with Quotient Therapeutics to uncover new drug targets for inflammatory bowel disease using Quotient’s somatic genomics platform. The deal provides Quotient with $20 million upfront and up to $2.2 billion in regulatory, development and...
Nearly 30 years in orthopedic surgery. Another pattern that is impossible to ignore. Perimenopausal women are some of the most undertreated patients I see. One unfortunate paper is blamed... but often, it's because the conversation never happens. https://t.co/6m6AxUhRKF
A recent BBC and New Statesman investigation uncovered preventable infant deaths at University Hospitals Sussex NHS Foundation Trust, highlighting a deepening maternal‑health crisis in the United Kingdom. Over the past 15 years, maternal mortality rates have risen steadily, exposing gaps in NHS...
Musculoskeletal (MSK) conditions remain the top driver of disability claims in the U.S., costing employers billions in lost productivity and medical expenses. The article argues that most of this spend is preventable through early, accessible care rather than reactive, high‑cost...
In 2024 more than 2.3 million Americans chose dental veneers, a 40% surge from five years earlier. Veneers combine cosmetic transformation with a protective seal that can preserve enamel and stave off costly restorative work such as crowns, which typically cost...
Royal Philips has launched IntraSight Plus, an FDA‑cleared and CE‑marked interventional cardiology platform that unifies intravascular ultrasound, iFR/FFR physiology, and angiographic imaging on a single screen. The system promises up to 47% reduction in procedure time by streamlining data entry...
The Milan Longevity Summit 2026, held May 20‑23 at Allianz MiCo, convenes leaders across finance, AI, agri‑food, urban design and more to re‑engineer systems for an aging world. Using the One Health framework, the event treats human longevity as intertwined...
Pixee Medical has secured a European CE mark for its Knee+ NexSight augmented‑reality platform, enabling the first EU total knee arthroplasty procedures using the technology. The system projects a voice‑controlled virtual overlay during surgery, delivering robotic‑level precision without a robot,...
Ventura Securities has initiated coverage on Park Medi World Ltd (PMWL) with a Buy rating and a $3.4 target price, suggesting roughly 38% upside over the next two years. The hospital chain, listed at $2.0 per share, leverages a capital‑efficient...
Ionis Pharmaceuticals received FDA acceptance of its new drug application for zilganersen and a priority‑review designation for treating Alexander disease, with a PDUFA target action date of September 22, 2026. The Phase III trial enrolled 54 patients aged 1.5 to 53...
In this episode, attorney Harrison James explains how the Racketeer Influenced and Corrupt Organizations Act (RICO), originally aimed at organized crime, is being used in a landmark civil class action against Takeda Pharmaceuticals and Eli Lilly over the diabetes drug Actos....
French imaging contrast agent maker Guerbet is confronting a severe FDA warning after inspectors found significant good manufacturing practice violations at its Raleigh, North Carolina plant. The citation has already depressed Americas revenue by 4% year‑over‑year and reduced MRI‑related sales,...
Harish Rana, a 31‑year‑old Indian man who had been in a coma since a 2013 balcony fall, died at AIIMS after the Supreme Court authorized the removal of his life‑support machines. The decision marks India’s first court‑approved instance of passive...
